MSK Department of Medicine shared an article by Kai Rejeski et al. on X:
“Congrats to Kai Rejeski, Roni Shouval, and their team on developing a new grading system to evaluate patterns of thrombocytopenia in patients treated with commercial CD19 CAR-T therapy for B-cell non-Hodgkin lymphoma.”
Title: T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Authors: Kai Rejeski, Jaime Sanz, Roni Shouval, et al.
Journal: Blood, April 2025
More posts featuring MSK Department of Medicine.